Icon

LuvoxCR - (100,150 mg; Capsule, Extended Release)

Fluvoxamine Maleate Jazz Pharma
100,150 mg; Capsule, Extended Release
Less Than $1000 mn
Less Than 5
Less Than 5
None None
Less Than 5
Less Than 5
Indicated for the treatment of obsessive compulsive disorder (OCD), as defined in the DSM-IV.
Yes
******* *** ****** ** ***** ** **** **** ** *** ******* ******** ** *** **, **** *** *** ************ ********* ** *** *********. ******* ****(****) & ***** ******** * ********** ********* ******* ** ***** *** *** *********. **** ***** ******* ***** **** ** **** ****** '*** *** *** ************ *********. ***** *** ********** *** ******* ********* ** *** ***** ** **** ******* *** ******* . ****** ******** ******* ** ***** **** **** *** **** ***********. *****, ******* **** ******** ******* ** *** ****.
LuvoxCR Patent 1
****** *******
******* *******
******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ *** ***** **, **** ******* ******** ******** ** ***** **, ****
******* *** \ ** ***** *, **** ******* ******** ******** ** *** *, ****
******* ** \ ** ***** **, **** ******* ******** ************ *********
  1. *** **, **** : ****** ***** **** ** **** ****** '*** *** *****
  2. *** **, **** : ****** ***** ******* **** ** **** ****** '*** *** *****
  3. ***, **** : ******* ******** ****(****) ***** *** **** ** ****** **** ***** & ***** ***** ******** *** ****** ******* (*** **, ****).
  4. *** *,**** : **** ***** * **** ******* ******* ** ******** ***** ** ********.
  5. *** **, **** : **** ***** * **** ******* ****** ** ******** ***** ** ********.
  6. *** *, **** : ****(****) & ****** ******** * ********** ********* ******* ** ***** *** *** *********.
  7. **** *, **** : ******* ******** **** ***** *** **** ** ****** **** ****** '*** *** *** & *****
  8. *** **, **** : **** ***** * **** ******* ******* ** ******** ***** ** ********.
  9. *** *, **** : **** ******* **** *******, ***** *** ***** ** ********** *** *** *****.
  10. *** **, **** : **** ******* **** ******* , ***** *** ***** ** ********** *** *** *****.
  11. *** **, **** : ****** *** ***** ******** *** *** *** *****

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.